Company: SNY
Filing Date: 2025-02-14
Form Type: SCHEDULE 13G/A
Source: 0001102598-25-000037
Chunk: 0

Company: Sanofi
Filing Date: 2025-02-14
Form: SCHEDULE 13G/A
Chunk 0
---
 control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |

| SIGNATURE |                                                                                                                                                                |
|           | After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. |

| AMUNDI |

| Signature:   /s/ Lisa M. Jones                                                                                                    
   Name/Title:  Lisa M. Jones; President and Chief Executive Officer; Head of the Americas Amundi US, Inc.; By Power of Attorney   
   Date:        02/12/2025                                                                                                         |

| Amundi Asset Management US, Inc. |

| Signature:   /s/ Lisa M. Jones                    
   Name/Title:  Amundi Asset Management US, Inc.   
   Date:        02/12/2025                         |

Comments accompanying signature:Lisa M. Jones; President and Chief Executive Officer; Head of the Americas Amundi US, Inc.; By Power of Attorney